Sort
23,748 grants matching “melanoma”
Melanoma antigens recognized by B and T helper lymphocytes
$312,755Wistar Institute · P01 · FY2001 · CA
Growth factors in tumor/stroma interactions during melanoma progression
$312,755Wistar Institute · P01 · FY2001 · CA
Expression pathways in melanoma progression for diagnosis and prognosis
$312,755Wistar Institute · P01 · FY2002 · CA
Core--Microarray analysis
$312,755Wistar Institute · P01 · FY2001 · CA
Water Soluble Antimitotics That Circumvent Rumor Resistance
$312,731Aleem Gangjee · Duquesne University · R01 · FY2011 · CA
Role of Polo-Like Kinase-1 in Melanocytic Transformation
$312,702Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2014 · AR
CORE--INFORMATICS, TISSUE RESOURCE, AND PATHOLOGY
$312,701Jeffrey E Gershenwald · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA
Biospecimen and Pathology Core
$312,544Xiaowei Xu · Wistar Institute · P50 · FY2014 · CA
Correlating Environmental & Genetic Risk Factors with Molecular Signatures in
$312,523David John Hunter · Brigham And Women'S Hospital · P50 · FY2010 · CA
Animal Models
$312,514Bernard E. Weissman · Univ Of North Carolina Chapel Hill · P30 · FY2020 · CA
Combinatorial targeting of melanoma initiating cells
$312,510Soldano Ferrone · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · CA
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose
$312,436Jonathan H Schatz · University Of Miami School Of Medicine · R01 · FY2015 · CA
Human engineered enzymes for L-Arg depletion chemotherapy
$312,409George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2009 · CA
Biology of Melanoma Matastasis
$312,321Meenhard Herlyn · Wistar Institute · R01 · FY2006 · CA
Role of SIRT1 in melanocyte biology and melanocyte transformation
$312,288Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2013 · CA
Role of SIRT1 in melanocyte biology and melanocyte transformation
$312,288Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2017 · CA
Validation of Genomic Targets in Melanoma
$312,281Mohammed Kashani-Sabet · California Pacific Med Ctr Res Institute · R01 · FY2015 · CA
GENETIC MODIFICATION OF HUMAN DENDRITIC CELLS FOR CANCER IMMUNITY
$312,246James W. Young · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
High-Throughput DNA-Methylation Profiling from Fixed Melanocytic Tissues
$312,242Nancy E Thomas · Univ Of North Carolina Chapel Hill · R33 · FY2013 · CA
Developmental bases for pigment cell variation in Danio
$312,228David M Parichy · University Of Washington · R01 · FY2011 · GM
Mechanistic Studies on New Platinum Clinical Agents
$312,194Nicholas P Farrell · Virginia Commonwealth University · R01 · FY2009 · CA
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
$312,186Duane A. Mitchell · Duke University · R01 · FY2011 · CA
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
$312,186Duane A. Mitchell · Duke University · R01 · FY2012 · CA
Synergistically Acting Targeted Therapeutics for Melanoma
$312,178Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · CA
Synergistically Acting Targeted Therapeutics for Melanoma
$312,178Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · CA